Shareholders

Shareholders in Chordate Medical Holding AB per 2021-12-31

Shareholder Number of shares Votes and capital %
HAWOC Investment AB  17 000 000 10,8%
Isak Brandberg AB 14 242 456 9,0%
 Sifonen AB  12 493 169 7,9%
 Tommy Hedberg  7 515 063 4,8%
Försäkringsbolaget Avanza Pension 7 155 714 4,5%
 Henrik Rammer  6 664 798 4,2%
 Bevaclean AB 6 375 000 4,0%
 Tiven GmbH 4 759 798 3,0%
Nordnet Pensionsförsäkring AB 3 492 000 2,2%
Magnum Invest med närstående 3 000 000 1,9%
Others 75 014 382 47,6%
Total 157 712 380 100,0%

We are a Swedish medical technology company listed on Nasdaq First North Growth Market.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

Please note that the MAR rules (Market Abuse Regulation) prohibits us from providing information to individual inquirers regarding matters of the company's share, share price, economy and financials, commercial and scientific activities, and other information that potentially can alter the Market valuation of the traded share. We refer in general to the public information published by the company for such questions. Hence, emails with such questions will not be responded to individually.

IR contact